Related content

Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels with risk of malignant melanoma

By Park Sungshim   Setiawan Veronica   Kanetsky Peter   Zhang Zuo-Feng   Wilkens Lynne   Kolonel Laurence   Marchand Loïc  

Cancer Causes and Control, Vol. 22, Iss. 9, 2011-09 ,pp. : 1267-1275

Springer Publishing Company

Access to resources Recommend Favorite

Variation in Plasma Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Protein-3: Personal and Lifestyle Factors (United States)

By Morimoto Libby M.  

Cancer Causes and Control, Vol. 16, Iss. 8, 2005-10 ,pp. : 917-927

Springer Publishing Company

Access to resources Recommend Favorite

Association of circulating insulin-like growth factor 1 and insulin-like growth factor binding protein 3 with the risk of ovarian cancer: A systematic review and meta-analysis

By          

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 623-628

Science Publishers

Access to resources Recommend Favorite

A pleiotropic effect of the single clustered hepatic metastamiRs miR-96-5p and miR-182-5p on insulin-like growth factor II, insulin-like growth factor-1 receptor and insulin-like growth factor-binding protein-3 in hepatocellular carcinoma

By          

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 645-650

Spandidos Publications

Access to resources Recommend Favorite

Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era

By Platz Elizabeth   Pollak Michael  

Cancer Causes and Control, Vol. 16, Iss. 3, 2005-04 ,pp. : 255-262

Springer Publishing Company

Access to resources Recommend Favorite